| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 4.62e-12 | 28 | 33 | 6 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.98e-11 | 35 | 33 | 6 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.47e-10 | 48 | 33 | 6 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.67e-10 | 49 | 33 | 6 | GO:0019840 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.02e-08 | 107 | 33 | 6 | GO:0033293 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.56e-08 | 303 | 33 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.71e-07 | 153 | 33 | 6 | GO:0008194 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.13e-06 | 211 | 33 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.33e-06 | 239 | 33 | 6 | GO:0031406 | |
| GeneOntologyMolecularFunction | steroid binding | 2.48e-06 | 133 | 33 | 5 | GO:0005496 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.79e-06 | 562 | 33 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | organic acid binding | 3.32e-06 | 254 | 33 | 6 | GO:0043177 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 4.14e-06 | 66 | 33 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | fatty acid binding | 4.95e-06 | 69 | 33 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 6.82e-06 | 288 | 33 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.07e-05 | 739 | 33 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 3.61e-05 | 39 | 33 | 3 | GO:0097718 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 4.24e-05 | 398 | 33 | 6 | GO:0046982 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 7.92e-05 | 1160 | 33 | 9 | GO:0030674 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 8.11e-05 | 51 | 33 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.02e-04 | 55 | 33 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.32e-04 | 60 | 33 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | lipid binding | 1.60e-04 | 988 | 33 | 8 | GO:0008289 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.60e-04 | 1356 | 33 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.74e-04 | 15 | 33 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.75e-04 | 560 | 33 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 2.88e-04 | 78 | 33 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.91e-04 | 566 | 33 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 3.10e-04 | 815 | 33 | 7 | GO:0042803 | |
| GeneOntologyMolecularFunction | SMAD binding | 3.83e-04 | 86 | 33 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | histone modifying activity | 5.31e-04 | 229 | 33 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 5.45e-04 | 21 | 33 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 5.68e-04 | 417 | 33 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 6.15e-04 | 1205 | 33 | 8 | GO:0046983 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 6.32e-04 | 102 | 33 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 6.68e-04 | 104 | 33 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 6.88e-04 | 435 | 33 | 5 | GO:0004857 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 1.73e-03 | 1412 | 33 | 8 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.12e-03 | 1459 | 33 | 8 | GO:0000977 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.50e-03 | 582 | 33 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | protein kinase binding | 2.76e-03 | 873 | 33 | 6 | GO:0019901 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 2.77e-03 | 596 | 33 | 5 | GO:0140678 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 2.79e-03 | 875 | 33 | 6 | GO:0019904 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 3.46e-03 | 53 | 33 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | kinase binding | 4.62e-03 | 969 | 33 | 6 | GO:0019900 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 5.32e-03 | 66 | 33 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 5.32e-03 | 66 | 33 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 7.01e-03 | 238 | 33 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | p53 binding | 7.17e-03 | 77 | 33 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | transcription factor binding | 7.44e-03 | 753 | 33 | 5 | GO:0008134 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 8.29e-03 | 83 | 33 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 8.48e-03 | 84 | 33 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.50e-02 | 1244 | 33 | 6 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.65e-02 | 1271 | 33 | 6 | GO:0000987 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.67e-02 | 120 | 33 | 2 | GO:0008013 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 4.57e-14 | 6 | 33 | 5 | GO:0051552 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 5.53e-13 | 21 | 33 | 6 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.33e-12 | 26 | 33 | 6 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.33e-12 | 26 | 33 | 6 | GO:0006063 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 9.73e-12 | 13 | 33 | 5 | GO:0009812 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 2.71e-11 | 5 | 33 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 2.71e-11 | 5 | 33 | 4 | GO:0052696 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 8.12e-11 | 6 | 33 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 8.12e-11 | 6 | 33 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.13e-09 | 10 | 33 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.13e-09 | 10 | 33 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.66e-09 | 12 | 33 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.88e-08 | 52 | 33 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 3.19e-08 | 21 | 33 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 8.73e-08 | 141 | 33 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CITED2 BCL9L NCOA3 KMT2C POU4F1 POU4F3 CTNNB1 BCL9 KAT6B PRDM4 CREBBP CREB5 TP63 | 8.97e-08 | 1390 | 33 | 13 | GO:0045944 |
| GeneOntologyBiologicalProcess | gland development | CITED2 UGT1A1 UGT1A9 NCOA3 CTNNB1 UGT1A10 UGT1A8 UGT1A7 TP63 | 1.57e-07 | 558 | 33 | 9 | GO:0048732 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 2.43e-07 | 34 | 33 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 3.79e-07 | 94 | 33 | 5 | GO:0042440 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 4.76e-07 | 40 | 33 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | liver development | 7.28e-07 | 202 | 33 | 6 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 7.93e-07 | 205 | 33 | 6 | GO:0061008 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 1.26e-06 | 222 | 33 | 6 | GO:0071466 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.85e-06 | 237 | 33 | 6 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 2.08e-06 | 242 | 33 | 6 | GO:0098727 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 3.88e-06 | 67 | 33 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | cranial nerve development | 3.88e-06 | 67 | 33 | 4 | GO:0021545 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 8.02e-06 | 306 | 33 | 6 | GO:0048863 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 1.20e-05 | 89 | 33 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.50e-05 | 94 | 33 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 2.32e-05 | 105 | 33 | 4 | GO:0006721 | |
| GeneOntologyBiologicalProcess | nerve development | 2.68e-05 | 109 | 33 | 4 | GO:0021675 | |
| GeneOntologyBiologicalProcess | cellular response to estradiol stimulus | 2.79e-05 | 37 | 33 | 3 | GO:0071392 | |
| GeneOntologyBiologicalProcess | response to estradiol | 5.04e-05 | 128 | 33 | 4 | GO:0032355 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 7.22e-05 | 276 | 33 | 5 | GO:0007179 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 7.71e-05 | 1194 | 33 | 9 | GO:0000902 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 7.97e-05 | 144 | 33 | 4 | GO:0006720 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 8.55e-05 | 286 | 33 | 5 | GO:0042445 | |
| GeneOntologyBiologicalProcess | ventricular compact myocardium morphogenesis | 8.87e-05 | 9 | 33 | 2 | GO:0003223 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 1.30e-04 | 731 | 33 | 7 | GO:0032787 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 1.63e-04 | 525 | 33 | 6 | GO:0009410 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | 1.77e-04 | 1035 | 33 | 8 | GO:0019752 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.82e-04 | 336 | 33 | 5 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.00e-04 | 343 | 33 | 5 | GO:0071559 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | 2.05e-04 | 1058 | 33 | 8 | GO:0043436 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 2.14e-04 | 1064 | 33 | 8 | GO:0006082 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 2.41e-04 | 192 | 33 | 4 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 2.56e-04 | 195 | 33 | 4 | GO:1903844 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in prostate gland development | 2.57e-04 | 15 | 33 | 2 | GO:0060742 | |
| GeneOntologyBiologicalProcess | animal organ formation | 2.62e-04 | 78 | 33 | 3 | GO:0048645 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 3.06e-04 | 376 | 33 | 5 | GO:0008202 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 3.50e-04 | 605 | 33 | 6 | GO:0071407 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial bud | 3.74e-04 | 18 | 33 | 2 | GO:0060572 | |
| GeneOntologyBiologicalProcess | genitalia morphogenesis | 3.74e-04 | 18 | 33 | 2 | GO:0035112 | |
| GeneOntologyBiologicalProcess | cellular response to hepatocyte growth factor stimulus | 4.17e-04 | 19 | 33 | 2 | GO:0035729 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 4.26e-04 | 223 | 33 | 4 | GO:0007519 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 4.64e-04 | 412 | 33 | 5 | GO:0090287 | |
| GeneOntologyBiologicalProcess | skeletal muscle cell differentiation | 4.82e-04 | 96 | 33 | 3 | GO:0035914 | |
| GeneOntologyBiologicalProcess | developmental growth | 5.00e-04 | 911 | 33 | 7 | GO:0048589 | |
| GeneOntologyBiologicalProcess | response to hepatocyte growth factor | 5.11e-04 | 21 | 33 | 2 | GO:0035728 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 5.27e-04 | 236 | 33 | 4 | GO:0061138 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 5.52e-04 | 239 | 33 | 4 | GO:0071383 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 5.61e-04 | 240 | 33 | 4 | GO:0060538 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 5.62e-04 | 22 | 33 | 2 | GO:0097091 | |
| GeneOntologyBiologicalProcess | growth | 5.84e-04 | 1235 | 33 | 8 | GO:0040007 | |
| GeneOntologyBiologicalProcess | muscle organ development | 6.01e-04 | 436 | 33 | 5 | GO:0007517 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 6.59e-04 | 445 | 33 | 5 | GO:0141091 | |
| GeneOntologyBiologicalProcess | odontogenesis of dentin-containing tooth | 6.61e-04 | 107 | 33 | 3 | GO:0042475 | |
| GeneOntologyBiologicalProcess | sympathetic nervous system development | 6.70e-04 | 24 | 33 | 2 | GO:0048485 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 6.79e-04 | 108 | 33 | 3 | GO:0035019 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 7.36e-04 | 258 | 33 | 4 | GO:0001763 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 8.33e-04 | 713 | 33 | 6 | GO:0048598 | |
| GeneOntologyBiologicalProcess | regulation of stem cell proliferation | 9.00e-04 | 119 | 33 | 3 | GO:0072091 | |
| GeneOntologyBiologicalProcess | lens morphogenesis in camera-type eye | 9.14e-04 | 28 | 33 | 2 | GO:0002089 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 9.22e-04 | 727 | 33 | 6 | GO:0032870 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 9.44e-04 | 482 | 33 | 5 | GO:0007178 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial fold | 9.81e-04 | 29 | 33 | 2 | GO:0060571 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.05e-03 | 284 | 33 | 4 | GO:0009913 | |
| GeneOntologyBiologicalProcess | response to hormone | 1.11e-03 | 1042 | 33 | 7 | GO:0009725 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 1.14e-03 | 1048 | 33 | 7 | GO:0014070 | |
| GeneOntologyBiologicalProcess | regulation of animal organ formation | 1.19e-03 | 32 | 33 | 2 | GO:0003156 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 1.23e-03 | 296 | 33 | 4 | GO:0048762 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.27e-03 | 515 | 33 | 5 | GO:0050767 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 1.30e-03 | 135 | 33 | 3 | GO:2000177 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 1.32e-03 | 1399 | 33 | 8 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 1.41e-03 | 1413 | 33 | 8 | GO:1902679 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 1.43e-03 | 35 | 33 | 2 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 1.43e-03 | 35 | 33 | 2 | GO:0030511 | |
| GeneOntologyBiologicalProcess | embryonic hindlimb morphogenesis | 1.43e-03 | 35 | 33 | 2 | GO:0035116 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 1.44e-03 | 1090 | 33 | 7 | GO:0022603 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 1.51e-03 | 36 | 33 | 2 | GO:0033146 | |
| GeneOntologyBiologicalProcess | negative regulation of steroid metabolic process | 1.51e-03 | 36 | 33 | 2 | GO:0045939 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.53e-03 | 802 | 33 | 6 | GO:0048812 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 1.59e-03 | 145 | 33 | 3 | GO:0045833 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 1.60e-03 | 37 | 33 | 2 | GO:0042537 | |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation | 1.60e-03 | 37 | 33 | 2 | GO:0009954 | |
| GeneOntologyBiologicalProcess | embryonic forelimb morphogenesis | 1.60e-03 | 37 | 33 | 2 | GO:0035115 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 9.22e-07 | 13 | 32 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 3.13e-06 | 272 | 32 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L NCOA3 KMT2C POU4F1 CTNNB1 BCL9 PRDM4 CREBBP PRPF40A UBQLN4 | 2.52e-05 | 1377 | 32 | 10 | GO:0140513 |
| GeneOntologyCellularComponent | transcription regulator complex | 2.68e-05 | 596 | 32 | 7 | GO:0005667 | |
| GeneOntologyCellularComponent | chromatin | 2.75e-04 | 1480 | 32 | 9 | GO:0000785 | |
| HumanPheno | Short ear | 1.27e-05 | 3 | 11 | 2 | HP:0400005 | |
| HumanPheno | Supernumerary tooth | 2.18e-05 | 85 | 11 | 4 | HP:0011069 | |
| MousePheno | absent hair follicles | 5.90e-05 | 7 | 24 | 2 | MP:0000378 | |
| MousePheno | abnormal maxilla morphology | 9.78e-05 | 144 | 24 | 4 | MP:0000455 | |
| MousePheno | abnormal vagina epithelium morphology | 1.01e-04 | 9 | 24 | 2 | MP:0001140 | |
| MousePheno | abnormal tooth morphology | 1.76e-04 | 318 | 24 | 5 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 1.78e-04 | 319 | 24 | 5 | MP:0030254 | |
| MousePheno | flattened snout | 1.85e-04 | 12 | 24 | 2 | MP:0000447 | |
| MousePheno | abnormal ocular surface morphology | 1.98e-04 | 67 | 24 | 3 | MP:0013754 | |
| MousePheno | abnormal jaw morphology | 2.17e-04 | 530 | 24 | 6 | MP:0000454 | |
| MousePheno | supernumerary teeth | 2.18e-04 | 13 | 24 | 2 | MP:0004033 | |
| MousePheno | abnormal cranium morphology | 3.17e-04 | 813 | 24 | 7 | MP:0000438 | |
| MousePheno | abnormal craniofacial bone morphology | 3.52e-04 | 827 | 24 | 7 | MP:0002116 | |
| MousePheno | abnormal prenatal body size | 3.71e-04 | 1116 | 24 | 8 | MP:0010866 | |
| MousePheno | small cochlear ganglion | 3.78e-04 | 17 | 24 | 2 | MP:0003986 | |
| MousePheno | abnormal viscerocranium morphology | 3.97e-04 | 593 | 24 | 6 | MP:0005274 | |
| Domain | UDPGT | 1.00e-12 | 21 | 33 | 6 | PS00375 | |
| Domain | UDPGT | 1.00e-12 | 21 | 33 | 6 | PF00201 | |
| Domain | UDP_glucos_trans | 1.00e-12 | 21 | 33 | 6 | IPR002213 | |
| Domain | BCL9_beta-catenin-bd_dom | 3.03e-06 | 2 | 33 | 2 | IPR024670 | |
| Domain | BCL9 | 3.03e-06 | 2 | 33 | 2 | PF11502 | |
| Domain | Bcl-9 | 3.03e-06 | 2 | 33 | 2 | IPR015668 | |
| Domain | Nuc_rcpt_coact | 4.52e-05 | 6 | 33 | 2 | IPR009110 | |
| Domain | POU | 3.58e-04 | 16 | 33 | 2 | SM00352 | |
| Domain | POU_2 | 3.58e-04 | 16 | 33 | 2 | PS00465 | |
| Domain | Pou | 3.58e-04 | 16 | 33 | 2 | PF00157 | |
| Domain | POU_dom | 3.58e-04 | 16 | 33 | 2 | IPR000327 | |
| Domain | POU_3 | 3.58e-04 | 16 | 33 | 2 | PS51179 | |
| Domain | POU_1 | 3.58e-04 | 16 | 33 | 2 | PS00035 | |
| Domain | POU | 4.05e-04 | 17 | 33 | 2 | IPR013847 | |
| Domain | - | 1.03e-03 | 27 | 33 | 2 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 1.19e-03 | 29 | 33 | 2 | IPR010982 | |
| Domain | Homeodomain-like | 2.67e-03 | 332 | 33 | 4 | IPR009057 | |
| Domain | SET | 2.98e-03 | 46 | 33 | 2 | SM00317 | |
| Domain | SET_dom | 3.52e-03 | 50 | 33 | 2 | IPR001214 | |
| Domain | SET | 3.52e-03 | 50 | 33 | 2 | PS50280 | |
| Domain | Znf_CCCH | 4.70e-03 | 58 | 33 | 2 | IPR000571 | |
| Domain | ZF_C3H1 | 4.70e-03 | 58 | 33 | 2 | PS50103 | |
| Domain | PHD | 7.75e-03 | 75 | 33 | 2 | PF00628 | |
| Domain | Homeobox | 8.03e-03 | 234 | 33 | 3 | PF00046 | |
| Domain | HOMEOBOX_1 | 8.22e-03 | 236 | 33 | 3 | PS00027 | |
| Domain | HOX | 8.31e-03 | 237 | 33 | 3 | SM00389 | |
| Domain | Homeobox_dom | 8.51e-03 | 239 | 33 | 3 | IPR001356 | |
| Domain | HOMEOBOX_2 | 8.51e-03 | 239 | 33 | 3 | PS50071 | |
| Domain | Znf_PHD-finger | 8.57e-03 | 79 | 33 | 2 | IPR019787 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.66e-12 | 25 | 26 | 6 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 3.66e-12 | 25 | 26 | 6 | M605 | |
| Pathway | WP_GLUCURONIDATION | 4.75e-12 | 26 | 26 | 6 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 7.76e-12 | 28 | 26 | 6 | M19580 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 2.81e-11 | 14 | 26 | 5 | M39328 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 9.11e-11 | 41 | 26 | 6 | M7399 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 3.60e-10 | 51 | 26 | 6 | M17726 | |
| Pathway | WP_ESTROGEN_METABOLISM | 3.66e-10 | 22 | 26 | 5 | MM15888 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.07e-10 | 52 | 26 | 6 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 5.77e-10 | 55 | 26 | 6 | M14933 | |
| Pathway | REACTOME_GLUCURONIDATION | 5.89e-10 | 24 | 26 | 5 | MM14599 | |
| Pathway | WP_GLUCURONIDATION | 7.35e-10 | 25 | 26 | 5 | MM15820 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.48e-09 | 64 | 26 | 6 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.56e-09 | 70 | 26 | 6 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.05e-09 | 72 | 26 | 6 | M9257 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 7.83e-09 | 39 | 26 | 5 | MM15695 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.47e-08 | 44 | 26 | 5 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.65e-08 | 45 | 26 | 5 | MM15694 | |
| Pathway | REACTOME_DRUG_ADME | 3.78e-08 | 109 | 26 | 6 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.78e-08 | 109 | 26 | 6 | M18788 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 2.07e-07 | 145 | 26 | 6 | M45512 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.09e-07 | 29 | 26 | 4 | M45015 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 3.16e-07 | 32 | 26 | 4 | M39567 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 1.21e-06 | 12 | 26 | 3 | M39611 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 1.29e-06 | 45 | 26 | 4 | M39615 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.33e-06 | 107 | 26 | 5 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 2.25e-06 | 119 | 26 | 5 | MM15692 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.39e-06 | 220 | 26 | 6 | M10320 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 4.46e-06 | 18 | 26 | 3 | M39424 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 7.72e-06 | 153 | 26 | 5 | MM15844 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.41e-05 | 26 | 26 | 3 | MM14793 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.84e-05 | 183 | 26 | 5 | M39588 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.18e-05 | 91 | 26 | 4 | M27101 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 2.42e-05 | 31 | 26 | 3 | M39476 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 3.26e-05 | 5 | 26 | 2 | M27228 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS | 3.26e-05 | 5 | 26 | 2 | M48304 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 4.36e-05 | 219 | 26 | 5 | MM14838 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 6.10e-05 | 42 | 26 | 3 | M27272 | |
| Pathway | WP_NRF2_PATHWAY | 1.21e-04 | 141 | 26 | 4 | M39454 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.78e-04 | 11 | 26 | 2 | M26924 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.13e-04 | 12 | 26 | 2 | M27765 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 2.38e-04 | 314 | 26 | 5 | M39428 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION | 2.52e-04 | 13 | 26 | 2 | M47595 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 2.94e-04 | 14 | 26 | 2 | M27638 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 2.94e-04 | 14 | 26 | 2 | MM15341 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.38e-04 | 15 | 26 | 2 | MM1439 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 3.38e-04 | 15 | 26 | 2 | M48323 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.86e-04 | 16 | 26 | 2 | M8516 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 3.86e-04 | 16 | 26 | 2 | M27940 | |
| Pathway | KEGG_PROSTATE_CANCER | 5.69e-04 | 89 | 26 | 3 | M13191 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 6.08e-04 | 91 | 26 | 3 | M39700 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE | 6.09e-04 | 20 | 26 | 2 | M27628 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 6.72e-04 | 21 | 26 | 2 | M39631 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 7.39e-04 | 22 | 26 | 2 | MM1370 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 8.08e-04 | 23 | 26 | 2 | MM1527 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 8.17e-04 | 233 | 26 | 4 | M27099 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 8.81e-04 | 24 | 26 | 2 | M16517 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 8.81e-04 | 24 | 26 | 2 | M46445 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 1.03e-03 | 26 | 26 | 2 | M39407 | |
| Pathway | WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME | 1.29e-03 | 29 | 26 | 2 | M39890 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.29e-03 | 118 | 26 | 3 | M27316 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.38e-03 | 30 | 26 | 2 | M207 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.42e-03 | 122 | 26 | 3 | M29689 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3 | 1.57e-03 | 32 | 26 | 2 | M40041 | |
| Pathway | PID_HIF2PATHWAY | 1.77e-03 | 34 | 26 | 2 | M44 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 1.98e-03 | 137 | 26 | 3 | M145 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.21e-03 | 38 | 26 | 2 | M27757 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 2.93e-03 | 330 | 26 | 4 | M7847 | |
| Pathway | PID_HNF3A_PATHWAY | 2.95e-03 | 44 | 26 | 2 | M285 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES | 2.95e-03 | 44 | 26 | 2 | M27499 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.97e-03 | 158 | 26 | 3 | MM14791 | |
| Pathway | PID_PS1_PATHWAY | 3.22e-03 | 46 | 26 | 2 | M70 | |
| Pathway | PID_AJDISS_2PATHWAY | 3.50e-03 | 48 | 26 | 2 | M142 | |
| Pathway | WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING | 3.65e-03 | 49 | 26 | 2 | M39683 | |
| Pathway | PID_FOXO_PATHWAY | 3.65e-03 | 49 | 26 | 2 | M136 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY | 3.95e-03 | 51 | 26 | 2 | M48267 | |
| Pathway | WP_WNT_SIGNALING_WP363 | 3.95e-03 | 51 | 26 | 2 | M39721 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 4.10e-03 | 52 | 26 | 2 | M2404 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 4.25e-03 | 53 | 26 | 2 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 4.57e-03 | 55 | 26 | 2 | M39351 | |
| Pathway | WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES | 4.91e-03 | 57 | 26 | 2 | M39877 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 5.25e-03 | 59 | 26 | 2 | M39886 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 6.15e-03 | 64 | 26 | 2 | M200 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 6.15e-03 | 64 | 26 | 2 | M27046 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 6.34e-03 | 65 | 26 | 2 | M39682 | |
| Pathway | PID_HIF1_TFPATHWAY | 6.53e-03 | 66 | 26 | 2 | M255 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 6.53e-03 | 66 | 26 | 2 | M27938 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 7.11e-03 | 69 | 26 | 2 | M48052 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 7.11e-03 | 69 | 26 | 2 | M46439 | |
| Pubmed | 1.26e-17 | 8 | 33 | 6 | 17179145 | ||
| Pubmed | 1.26e-17 | 8 | 33 | 6 | 20610558 | ||
| Pubmed | 3.78e-17 | 9 | 33 | 6 | 22511988 | ||
| Pubmed | 9.44e-17 | 10 | 33 | 6 | 23642732 | ||
| Pubmed | 9.44e-17 | 10 | 33 | 6 | 11465080 | ||
| Pubmed | 9.44e-17 | 10 | 33 | 6 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 9.44e-17 | 10 | 33 | 6 | 22558097 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 4.15e-16 | 12 | 33 | 6 | 20308471 | |
| Pubmed | 4.15e-16 | 12 | 33 | 6 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 4.15e-16 | 12 | 33 | 6 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 7.70e-16 | 13 | 33 | 6 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 7.70e-16 | 13 | 33 | 6 | 25246029 | |
| Pubmed | 1.35e-15 | 14 | 33 | 6 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.35e-15 | 14 | 33 | 6 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.35e-15 | 14 | 33 | 6 | 14672974 | |
| Pubmed | 1.35e-15 | 14 | 33 | 6 | 9295054 | ||
| Pubmed | 3.36e-15 | 6 | 33 | 5 | 20297805 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 3.59e-15 | 16 | 33 | 6 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 5.54e-15 | 17 | 33 | 6 | 20639394 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.17e-14 | 7 | 33 | 5 | 8467709 | |
| Pubmed | 1.17e-14 | 7 | 33 | 5 | 8464825 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.21e-14 | 19 | 33 | 6 | 23281178 | |
| Pubmed | 3.13e-14 | 8 | 33 | 5 | 18052087 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 6.00e-14 | 24 | 33 | 6 | 24625756 | |
| Pubmed | 2.58e-13 | 11 | 33 | 5 | 18695635 | ||
| Pubmed | 6.71e-13 | 4 | 33 | 4 | 17558305 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 6.71e-13 | 4 | 33 | 4 | 2108603 | |
| Pubmed | 4.76e-12 | 18 | 33 | 5 | 20056724 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 1.01e-11 | 6 | 33 | 4 | 19204906 | |
| Pubmed | 1.01e-11 | 6 | 33 | 4 | 32527940 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 1.58e-11 | 57 | 33 | 6 | 21886157 | |
| Pubmed | 2.35e-11 | 7 | 33 | 4 | 27514509 | ||
| Pubmed | 3.94e-11 | 66 | 33 | 6 | 19898482 | ||
| Pubmed | 4.69e-11 | 8 | 33 | 4 | 15319294 | ||
| Pubmed | 8.43e-11 | 9 | 33 | 4 | 1339448 | ||
| Pubmed | 6.68e-10 | 14 | 33 | 4 | 28174279 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 15247627 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 19364970 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 29519853 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 34545187 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 7.78e-10 | 3 | 33 | 3 | 20007669 | |
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 33649334 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 26247833 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 12732365 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 7.78e-10 | 3 | 33 | 3 | 24453052 | |
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 20860988 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 19712005 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 23789755 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 17406868 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 19996319 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 12847094 | ||
| Pubmed | Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. | 7.78e-10 | 3 | 33 | 3 | 16969497 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.02e-09 | 211 | 33 | 7 | 24097068 | |
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 24255116 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 1634050 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 1898728 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 18347063 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 20628391 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 15855726 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 8276413 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 8280139 | ||
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 7.77e-09 | 5 | 33 | 3 | 18597651 | |
| Pubmed | LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. | 7.77e-09 | 5 | 33 | 3 | 24360964 | |
| Pubmed | 7.77e-09 | 5 | 33 | 3 | 17052462 | ||
| Pubmed | 7.77e-09 | 5 | 33 | 3 | 20565459 | ||
| Pubmed | 7.77e-09 | 5 | 33 | 3 | 15057901 | ||
| Pubmed | 7.77e-09 | 5 | 33 | 3 | 19328798 | ||
| Pubmed | 1.55e-08 | 6 | 33 | 3 | 17113272 | ||
| Pubmed | Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer. | 1.55e-08 | 6 | 33 | 3 | 30760720 | |
| Pubmed | 1.55e-08 | 6 | 33 | 3 | 15574752 | ||
| Pubmed | Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development. | 1.55e-08 | 6 | 33 | 3 | 25184676 | |
| Pubmed | 2.41e-08 | 190 | 33 | 6 | 24816252 | ||
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 3.57e-08 | 203 | 33 | 6 | 16916647 | |
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 4.34e-08 | 8 | 33 | 3 | 12695355 | |
| Pubmed | 4.34e-08 | 8 | 33 | 3 | 22579593 | ||
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 4.34e-08 | 8 | 33 | 3 | 28296634 | |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 6.51e-08 | 9 | 33 | 3 | 20732626 | |
| Pubmed | Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. | 1.70e-07 | 12 | 33 | 3 | 19349540 | |
| Pubmed | 1.70e-07 | 12 | 33 | 3 | 18161889 | ||
| Pubmed | 1.84e-07 | 268 | 33 | 6 | 33640491 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.05e-07 | 457 | 33 | 7 | 32344865 | |
| Pubmed | 2.56e-07 | 57 | 33 | 4 | 18022353 | ||
| Pubmed | 4.32e-07 | 16 | 33 | 3 | 20972438 | ||
| Pubmed | Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. | 8.73e-07 | 2 | 33 | 2 | 15864130 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 15929176 | ||
| Pubmed | Interethnic Variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population. | 8.73e-07 | 2 | 33 | 2 | 31132973 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 9627603 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 9639672 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 9621515 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 8226884 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 18675828 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 18349289 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 10946897 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 28675294 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 18981166 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 30009824 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 25547628 | ||
| Pubmed | Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. | 8.73e-07 | 2 | 33 | 2 | 7715297 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 12480553 | ||
| Interaction | GSC interactions | 2.88e-07 | 87 | 33 | 5 | int:GSC | |
| Interaction | EGR2 interactions | 3.13e-07 | 171 | 33 | 6 | int:EGR2 | |
| Interaction | SP7 interactions | 5.06e-07 | 304 | 33 | 7 | int:SP7 | |
| Interaction | TFF1 interactions | 5.78e-07 | 41 | 33 | 4 | int:TFF1 | |
| Interaction | KLF5 interactions | 6.77e-07 | 195 | 33 | 6 | int:KLF5 | |
| Interaction | PYGO2 interactions | 1.10e-06 | 48 | 33 | 4 | int:PYGO2 | |
| Interaction | UGT1A9 interactions | 1.13e-06 | 13 | 33 | 3 | int:UGT1A9 | |
| Interaction | UGT1A7 interactions | 2.21e-06 | 57 | 33 | 4 | int:UGT1A7 | |
| Interaction | GCM1 interactions | 4.51e-06 | 68 | 33 | 4 | int:GCM1 | |
| Interaction | NUP35 interactions | 4.62e-06 | 424 | 33 | 7 | int:NUP35 | |
| Interaction | ETV4 interactions | 4.78e-06 | 69 | 33 | 4 | int:ETV4 | |
| Interaction | KLF4 interactions | 5.88e-06 | 160 | 33 | 5 | int:KLF4 | |
| Interaction | SMAD3 interactions | 6.53e-06 | 447 | 33 | 7 | int:SMAD3 | |
| Interaction | UGT1A8 interactions | 7.79e-06 | 3 | 33 | 2 | int:UGT1A8 | |
| Interaction | HNF1A interactions | 8.63e-06 | 80 | 33 | 4 | int:HNF1A | |
| Interaction | PYGO1 interactions | 1.27e-05 | 28 | 33 | 3 | int:PYGO1 | |
| Interaction | HNF1B interactions | 1.35e-05 | 190 | 33 | 5 | int:HNF1B | |
| Interaction | FOXI1 interactions | 1.50e-05 | 92 | 33 | 4 | int:FOXI1 | |
| Interaction | SOX17 interactions | 1.71e-05 | 95 | 33 | 4 | int:SOX17 | |
| Interaction | SOX9 interactions | 1.85e-05 | 97 | 33 | 4 | int:SOX9 | |
| Interaction | UGT1A10 interactions | 2.11e-05 | 33 | 33 | 3 | int:UGT1A10 | |
| Interaction | AR interactions | 2.16e-05 | 992 | 33 | 9 | int:AR | |
| Interaction | ERG interactions | 2.92e-05 | 223 | 33 | 5 | int:ERG | |
| Interaction | PAX8 interactions | 3.15e-05 | 111 | 33 | 4 | int:PAX8 | |
| Interaction | TBR1 interactions | 3.38e-05 | 113 | 33 | 4 | int:TBR1 | |
| Interaction | IKBKB interactions | 3.61e-05 | 233 | 33 | 5 | int:IKBKB | |
| Interaction | TBXT interactions | 3.75e-05 | 116 | 33 | 4 | int:TBXT | |
| Interaction | PAX7 interactions | 4.87e-05 | 124 | 33 | 4 | int:PAX7 | |
| Interaction | CRX interactions | 5.44e-05 | 254 | 33 | 5 | int:CRX | |
| Interaction | PAX9 interactions | 5.85e-05 | 130 | 33 | 4 | int:PAX9 | |
| Interaction | BCL9L interactions | 6.58e-05 | 48 | 33 | 3 | int:BCL9L | |
| Interaction | EWSR1 interactions | 8.24e-05 | 906 | 33 | 8 | int:EWSR1 | |
| Interaction | NFIB interactions | 8.25e-05 | 142 | 33 | 4 | int:NFIB | |
| Interaction | CYFIP1 interactions | 1.25e-04 | 303 | 33 | 5 | int:CYFIP1 | |
| Interaction | FOS interactions | 1.43e-04 | 312 | 33 | 5 | int:FOS | |
| Interaction | SMG7 interactions | 1.59e-04 | 319 | 33 | 5 | int:SMG7 | |
| Interaction | RXRA interactions | 1.62e-04 | 169 | 33 | 4 | int:RXRA | |
| Interaction | C14orf39 interactions | 1.70e-04 | 12 | 33 | 2 | int:C14orf39 | |
| Interaction | TLX1 interactions | 1.85e-04 | 175 | 33 | 4 | int:TLX1 | |
| Interaction | DTX2 interactions | 1.86e-04 | 330 | 33 | 5 | int:DTX2 | |
| Interaction | CPSF6 interactions | 1.87e-04 | 526 | 33 | 6 | int:CPSF6 | |
| Interaction | AIF1 interactions | 2.01e-04 | 13 | 33 | 2 | int:AIF1 | |
| Interaction | LHX2 interactions | 2.19e-04 | 183 | 33 | 4 | int:LHX2 | |
| Interaction | LHX3 interactions | 2.28e-04 | 185 | 33 | 4 | int:LHX3 | |
| Interaction | GATA3 interactions | 2.38e-04 | 187 | 33 | 4 | int:GATA3 | |
| Interaction | JADE1 interactions | 2.69e-04 | 77 | 33 | 3 | int:JADE1 | |
| Interaction | MYOD1 interactions | 2.74e-04 | 194 | 33 | 4 | int:MYOD1 | |
| Interaction | GATA2 interactions | 3.02e-04 | 199 | 33 | 4 | int:GATA2 | |
| Interaction | SOX7 interactions | 3.24e-04 | 82 | 33 | 3 | int:SOX7 | |
| Interaction | FEV interactions | 3.25e-04 | 203 | 33 | 4 | int:FEV | |
| Interaction | TLE3 interactions | 3.40e-04 | 376 | 33 | 5 | int:TLE3 | |
| Interaction | CYP3A4 interactions | 3.48e-04 | 17 | 33 | 2 | int:CYP3A4 | |
| Interaction | PAX2 interactions | 3.61e-04 | 85 | 33 | 3 | int:PAX2 | |
| Interaction | BCL9 interactions | 3.73e-04 | 86 | 33 | 3 | int:BCL9 | |
| Interaction | SMAD2 interactions | 3.79e-04 | 385 | 33 | 5 | int:SMAD2 | |
| Interaction | SETDB1 interactions | 3.97e-04 | 214 | 33 | 4 | int:SETDB1 | |
| Interaction | SOX10 interactions | 4.55e-04 | 92 | 33 | 3 | int:SOX10 | |
| Interaction | CHUK interactions | 4.72e-04 | 224 | 33 | 4 | int:CHUK | |
| Interaction | ATF3 interactions | 4.84e-04 | 94 | 33 | 3 | int:ATF3 | |
| Interaction | RAI2 interactions | 4.85e-04 | 20 | 33 | 2 | int:RAI2 | |
| Interaction | HIPK2 interactions | 5.47e-04 | 98 | 33 | 3 | int:HIPK2 | |
| Interaction | CITED2 interactions | 6.44e-04 | 23 | 33 | 2 | int:CITED2 | |
| Interaction | NFYA interactions | 6.69e-04 | 105 | 33 | 3 | int:NFYA | |
| Interaction | TFAP2B interactions | 7.02e-04 | 24 | 33 | 2 | int:TFAP2B | |
| Interaction | ANKRD50 interactions | 7.26e-04 | 108 | 33 | 3 | int:ANKRD50 | |
| Interaction | EMX1 interactions | 7.62e-04 | 25 | 33 | 2 | int:EMX1 | |
| Interaction | ZNF639 interactions | 7.62e-04 | 25 | 33 | 2 | int:ZNF639 | |
| Interaction | KAT2B interactions | 7.79e-04 | 256 | 33 | 4 | int:KAT2B | |
| Interaction | JUN interactions | 9.35e-04 | 470 | 33 | 5 | int:JUN | |
| Interaction | HNF4A interactions | 1.02e-03 | 275 | 33 | 4 | int:HNF4A | |
| Interaction | RELA interactions | 1.08e-03 | 485 | 33 | 5 | int:RELA | |
| Interaction | RUNX2 interactions | 1.14e-03 | 126 | 33 | 3 | int:RUNX2 | |
| Interaction | KLF15 interactions | 1.24e-03 | 290 | 33 | 4 | int:KLF15 | |
| Interaction | PECAM1 interactions | 1.25e-03 | 32 | 33 | 2 | int:PECAM1 | |
| Interaction | TLX3 interactions | 1.25e-03 | 291 | 33 | 4 | int:TLX3 | |
| Cytoband | 2q37 | 6.19e-14 | 31 | 33 | 6 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 1.32e-08 | 226 | 33 | 6 | chr2q37 | |
| Cytoband | 1q21 | 1.97e-03 | 91 | 33 | 2 | 1q21 | |
| Cytoband | 14q24.3 | 2.06e-03 | 93 | 33 | 2 | 14q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q23 | 5.24e-03 | 150 | 33 | 2 | chr12q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q24 | 9.12e-03 | 200 | 33 | 2 | chr14q24 | |
| GeneFamily | UDP glucuronosyltransferases | 2.46e-12 | 32 | 24 | 6 | 363 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.38e-06 | 17 | 24 | 3 | 486 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 4.20e-04 | 23 | 24 | 2 | 523 | |
| GeneFamily | Zinc fingers CCCH-type | 9.78e-04 | 35 | 24 | 2 | 73 | |
| GeneFamily | PHD finger proteins | 6.30e-03 | 90 | 24 | 2 | 88 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | 1.74e-05 | 946 | 33 | 8 | M39169 | |
| Coexpression | NFE2L2.V2 | 2.34e-05 | 469 | 33 | 6 | M2870 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.47e-05 | 300 | 33 | 5 | M8702 | |
| Coexpression | SCHEIDEREIT_IKK_INTERACTING_PROTEINS | 4.08e-05 | 53 | 33 | 3 | M6303 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR | 4.11e-05 | 154 | 33 | 4 | MM1313 | |
| Coexpression | GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN | 1.03e-04 | 195 | 33 | 4 | M9804 | |
| Coexpression | GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP | 1.13e-04 | 200 | 33 | 4 | M3523 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 2.54e-07 | 187 | 33 | 5 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.12e-07 | 195 | 33 | 5 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.40e-06 | 157 | 33 | 4 | 70fd6c46db4250c7de5c4686a9500689402737f6 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.40e-06 | 157 | 33 | 4 | dd08dc19d434e94a194076c462ee273c682abf55 | |
| ToppCell | Basal_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.53e-06 | 158 | 33 | 4 | dd069a822e9698e6dddc155d9a5b52383f7879d5 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.11e-06 | 162 | 33 | 4 | 7f9385aa749bfb2fa9fee6939fe46d946bc21d31 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 7.56e-06 | 171 | 33 | 4 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.74e-06 | 172 | 33 | 4 | 94842346c84542a5243bd765e49f4af8bc5182db | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-06 | 172 | 33 | 4 | bd01b39a5699824ab14827cc9dc98e547d65b160 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.74e-06 | 172 | 33 | 4 | 5d654dd030ed22a701e15c5f09002951d99a52e8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.10e-06 | 174 | 33 | 4 | 911eac6f6ec1e5e85348a7fe774243498388a810 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.67e-06 | 177 | 33 | 4 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.67e-06 | 177 | 33 | 4 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.06e-06 | 179 | 33 | 4 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.46e-06 | 181 | 33 | 4 | 88f6f56f5f58b479d5db91b32c45934c045f88ea | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.01e-05 | 184 | 33 | 4 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-05 | 186 | 33 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.17e-05 | 191 | 33 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-05 | 195 | 33 | 4 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.29e-05 | 196 | 33 | 4 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-2|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.22e-05 | 104 | 33 | 3 | 57d2a707aacaa90f92895b87f4ecf87b7451d667 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-04 | 132 | 33 | 3 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-04 | 132 | 33 | 3 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.91e-04 | 152 | 33 | 3 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | Basal_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.15e-04 | 158 | 33 | 3 | 51e3ed1b91b010404d66e3e7efdbffc0c815e25b | |
| ToppCell | Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, Lineage and Cell Type | 2.15e-04 | 158 | 33 | 3 | 05a29c2d5506a25ccdfa4c6a86e9188977a18272 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 161 | 33 | 3 | d431625c32f59a6b552191f3adc5198bd16ad5cf | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 161 | 33 | 3 | da9eecf919866a9c579d7a707a996cf335213134 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.71e-04 | 171 | 33 | 3 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.75e-04 | 172 | 33 | 3 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 2.90e-04 | 175 | 33 | 3 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.90e-04 | 175 | 33 | 3 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.04e-04 | 178 | 33 | 3 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.09e-04 | 179 | 33 | 3 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 3.09e-04 | 179 | 33 | 3 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.15e-04 | 180 | 33 | 3 | 535a890bde0d978b461c2d4c571529b585c76b21 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.20e-04 | 181 | 33 | 3 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 3.30e-04 | 183 | 33 | 3 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.35e-04 | 184 | 33 | 3 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 3.41e-04 | 185 | 33 | 3 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.41e-04 | 185 | 33 | 3 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.41e-04 | 185 | 33 | 3 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.41e-04 | 185 | 33 | 3 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 3.41e-04 | 185 | 33 | 3 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 3.41e-04 | 185 | 33 | 3 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.46e-04 | 186 | 33 | 3 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.46e-04 | 186 | 33 | 3 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.46e-04 | 186 | 33 | 3 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 3.52e-04 | 187 | 33 | 3 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 3.52e-04 | 187 | 33 | 3 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 188 | 33 | 3 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-04 | 189 | 33 | 3 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.63e-04 | 189 | 33 | 3 | 59e6fec454de621119571d4a8ec48be3bf02a32e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 189 | 33 | 3 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.63e-04 | 189 | 33 | 3 | 43f25fb7257eab05df921ffcd5a6e49c78a03e3a | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.68e-04 | 190 | 33 | 3 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.68e-04 | 190 | 33 | 3 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.68e-04 | 190 | 33 | 3 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 3.68e-04 | 190 | 33 | 3 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.68e-04 | 190 | 33 | 3 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.74e-04 | 191 | 33 | 3 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.74e-04 | 191 | 33 | 3 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.74e-04 | 191 | 33 | 3 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.86e-04 | 193 | 33 | 3 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.97e-04 | 195 | 33 | 3 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-04 | 196 | 33 | 3 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | COPD-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 4.03e-04 | 196 | 33 | 3 | af96fb94886e9395f3e2cd0a293af29229d017fe | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 4.09e-04 | 197 | 33 | 3 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.09e-04 | 197 | 33 | 3 | 2cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.09e-04 | 197 | 33 | 3 | 2701864e49878c5f323f5133e2c4b0a5a7fff7f5 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.09e-04 | 197 | 33 | 3 | 751f19b00f92e1334f653b870d3f7c0c149ff41a | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.09e-04 | 197 | 33 | 3 | 4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.09e-04 | 197 | 33 | 3 | 58d809ccb8cc4b1e76acf0b8f996cd0e2637290c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-04 | 197 | 33 | 3 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.09e-04 | 197 | 33 | 3 | 0f37afad46b94c748a149d9ee681472d7a3e6937 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-04 | 197 | 33 | 3 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 4.16e-04 | 198 | 33 | 3 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-04 | 198 | 33 | 3 | 43a2ce64fa309bac89a44ea320e87ae2cc39f782 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-04 | 198 | 33 | 3 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-04 | 198 | 33 | 3 | 731a90f7e68b19e387499d63e3979af78b503b0c | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.16e-04 | 198 | 33 | 3 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.22e-04 | 199 | 33 | 3 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, condition lineage and cell class | 4.22e-04 | 199 | 33 | 3 | c10c8c9322cad4996e4aa11a8680e3d781644ace | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, condition lineage and cell class | 4.22e-04 | 199 | 33 | 3 | 1b17e6d5e6b994dec65efae2667f4f1f438161b1 | |
| ToppCell | PSB-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.22e-04 | 199 | 33 | 3 | 2add64c3e4cb6384ec381f34c3f1f77e13e3f27c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-TH--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.28e-04 | 200 | 33 | 3 | e9b5105fff7845a98f962d609c2055528583b48e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.28e-04 | 200 | 33 | 3 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.28e-04 | 200 | 33 | 3 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Biopsy_Other_PF-Epithelial-Basal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.28e-04 | 200 | 33 | 3 | 7098ae4b0ea8ba607519eaed8577c577530fc2a1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.28e-04 | 200 | 33 | 3 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-TH-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.28e-04 | 200 | 33 | 3 | fa0d4a0c93b0b0ad0331e7b7013373be27958c4e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-TH|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.28e-04 | 200 | 33 | 3 | 3ece392f336547aea7dea625d9102819b04b4f7a | |
| Drug | AC1MRQNQ | 4.80e-16 | 9 | 33 | 6 | CID003522271 | |
| Drug | DHPASiU | 4.80e-16 | 9 | 33 | 6 | CID000197602 | |
| Drug | Chebi:32663 | 4.80e-16 | 9 | 33 | 6 | CID005460873 | |
| Drug | 3-iodophenol | 4.80e-16 | 9 | 33 | 6 | CID000012272 | |
| Drug | AC1L4J7U | 4.80e-16 | 9 | 33 | 6 | CID000186631 | |
| Drug | 4-nitrophenyl)imidazole | 2.63e-15 | 11 | 33 | 6 | CID000123155 | |
| Drug | AC1O5XMV | 2.63e-15 | 11 | 33 | 6 | CID006442661 | |
| Drug | naringenin chalcone | 4.66e-15 | 5 | 33 | 5 | ctd:C027329 | |
| Drug | anthrarobin | 4.66e-15 | 5 | 33 | 5 | ctd:C032186 | |
| Drug | N-OH-DABZ | 5.26e-15 | 12 | 33 | 6 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 5.26e-15 | 12 | 33 | 6 | CID000088735 | |
| Drug | 2,4,6-TCB | 5.26e-15 | 12 | 33 | 6 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 5.26e-15 | 12 | 33 | 6 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 5.26e-15 | 12 | 33 | 6 | CID000160090 | |
| Drug | tritanol | 9.76e-15 | 13 | 33 | 6 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 9.76e-15 | 13 | 33 | 6 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 9.76e-15 | 13 | 33 | 6 | CID000000411 | |
| Drug | thymine | UGT1A1 UGT1A9 KMT2C APPL2 KAT6B ALDH6A1 CREBBP PRPF40A UGT1A10 UGT1A8 UGT1A7 UGT1A6 | 1.09e-14 | 315 | 33 | 12 | CID000001135 |
| Drug | propranolol glucuronide | 1.71e-14 | 14 | 33 | 6 | CID000119515 | |
| Drug | PCB-61 | 1.71e-14 | 14 | 33 | 6 | CID000036401 | |
| Drug | 4-ethylphenol | 1.74e-14 | 31 | 33 | 7 | CID000031242 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 2.79e-14 | 6 | 33 | 5 | ctd:C543211 | |
| Drug | alloin | 2.79e-14 | 6 | 33 | 5 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 2.79e-14 | 6 | 33 | 5 | ctd:C107497 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 2.84e-14 | 15 | 33 | 6 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 2.84e-14 | 15 | 33 | 6 | CID000010752 | |
| Drug | sulforaphane nitrile | 2.84e-14 | 15 | 33 | 6 | CID000543743 | |
| Drug | afloqualone | 2.84e-14 | 15 | 33 | 6 | CID000002040 | |
| Drug | naphthyl sulphate | 2.84e-14 | 15 | 33 | 6 | CID000114775 | |
| Drug | quercetin-3,4'-diglucoside | 4.54e-14 | 16 | 33 | 6 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 4.54e-14 | 16 | 33 | 6 | CID000040003 | |
| Drug | bilirubin-phosphate | 4.54e-14 | 16 | 33 | 6 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 7.01e-14 | 17 | 33 | 6 | CID000003573 | |
| Drug | 6-hydroxychrysene | 7.01e-14 | 17 | 33 | 6 | CID000037766 | |
| Drug | 2',4'-dihydroxychalcone | 9.76e-14 | 7 | 33 | 5 | ctd:C059354 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.05e-13 | 18 | 33 | 6 | CID000152226 | |
| Drug | Br 2 | 1.05e-13 | 18 | 33 | 6 | CID003060900 | |
| Drug | SureCN12722713 | 1.05e-13 | 18 | 33 | 6 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 1.05e-13 | 18 | 33 | 6 | CID000036614 | |
| Drug | ApApG | 1.05e-13 | 18 | 33 | 6 | CID003081975 | |
| Drug | C1 11-32 | 1.05e-13 | 18 | 33 | 6 | CID000443077 | |
| Drug | C11131 | 1.05e-13 | 18 | 33 | 6 | CID000443076 | |
| Drug | almokalant | 1.53e-13 | 19 | 33 | 6 | CID003033962 | |
| Drug | 9-OH-risperidone | 1.53e-13 | 19 | 33 | 6 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.53e-13 | 19 | 33 | 6 | CID000091433 | |
| Drug | tectochrysin | 2.19e-13 | 20 | 33 | 6 | CID005281954 | |
| Drug | AC1L1OBF | 2.19e-13 | 20 | 33 | 6 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 2.19e-13 | 20 | 33 | 6 | CID000116545 | |
| Drug | 1,4-dihydroxyanthraquinone | 2.60e-13 | 8 | 33 | 5 | ctd:C034890 | |
| Drug | estriol-16-glucuronide | 3.06e-13 | 21 | 33 | 6 | CID000122281 | |
| Drug | dulcin | 3.06e-13 | 21 | 33 | 6 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 3.06e-13 | 21 | 33 | 6 | CID000069186 | |
| Drug | amonafide | 4.21e-13 | 22 | 33 | 6 | CID000050515 | |
| Drug | N-methylpiperazine | 4.21e-13 | 22 | 33 | 6 | CID000053167 | |
| Drug | EM-652 | 5.60e-13 | 49 | 33 | 7 | CID000155435 | |
| Drug | amidoxime | 5.68e-13 | 23 | 33 | 6 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 5.68e-13 | 23 | 33 | 6 | CID000066651 | |
| Drug | phenanthridine | 5.68e-13 | 23 | 33 | 6 | CID000009189 | |
| Drug | AS-3201 | 7.57e-13 | 24 | 33 | 6 | CID000153948 | |
| Drug | 5-MOP | 9.95e-13 | 25 | 33 | 6 | CID000002355 | |
| Drug | Hymecromone | 9.95e-13 | 25 | 33 | 6 | ctd:D006923 | |
| Drug | AzMC | 9.95e-13 | 25 | 33 | 6 | CID000064986 | |
| Drug | N-acetylbenzidine | 9.95e-13 | 25 | 33 | 6 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 9.95e-13 | 25 | 33 | 6 | CID000006796 | |
| Drug | N-phenylmaleimide | 9.95e-13 | 25 | 33 | 6 | CID000013662 | |
| Drug | 2,6-dihydroxyanthraquinone | 1.17e-12 | 10 | 33 | 5 | ctd:C034889 | |
| Drug | Scopoletin | 1.66e-12 | 27 | 33 | 6 | ctd:D012603 | |
| Drug | DiMeIQx | 1.66e-12 | 27 | 33 | 6 | CID000104739 | |
| Drug | licochalcone A | 1.66e-12 | 27 | 33 | 6 | ctd:C070840 | |
| Drug | diflunisal | 1.66e-12 | 27 | 33 | 6 | CID000003059 | |
| Drug | N-hydroxy-4-aminobiphenyl | 2.11e-12 | 28 | 33 | 6 | CID000081261 | |
| Drug | CARMINE | 2.11e-12 | 28 | 33 | 6 | CID000014749 | |
| Drug | erucin | 2.11e-12 | 28 | 33 | 6 | CID000078160 | |
| Drug | H-Ni | 2.11e-12 | 28 | 33 | 6 | CID000445665 | |
| Drug | AC1L1JAL | 2.66e-12 | 29 | 33 | 6 | CID000004954 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 2.66e-12 | 29 | 33 | 6 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 2.66e-12 | 29 | 33 | 6 | CID000000414 | |
| Drug | 7-hydroxycoumarin glucuronide | 2.66e-12 | 29 | 33 | 6 | CID000125641 | |
| Drug | iberin | 2.66e-12 | 29 | 33 | 6 | CID000010455 | |
| Drug | 3-OH | 2.81e-12 | 61 | 33 | 7 | CID000068152 | |
| Drug | AC1ND2OB | UGT1A1 UGT1A9 NCOA3 CTNNB1 CREBBP UGT1A10 UGT1A8 UGT1A7 UGT1A6 TP63 | 2.82e-12 | 265 | 33 | 10 | CID004568637 |
| Drug | tolcapone | 3.32e-12 | 30 | 33 | 6 | CID004659569 | |
| Drug | paricalcitol | 3.32e-12 | 30 | 33 | 6 | CID005281104 | |
| Drug | AC1L9E0Q | 3.32e-12 | 30 | 33 | 6 | CID000443095 | |
| Drug | dihydroartemisinin | 3.32e-12 | 30 | 33 | 6 | CID000107770 | |
| Drug | 4-hydroxyestrone | 3.66e-12 | 12 | 33 | 5 | ctd:C026418 | |
| Drug | PCB 156 | 4.11e-12 | 31 | 33 | 6 | CID000038019 | |
| Drug | 4'-HPPH | 4.11e-12 | 31 | 33 | 6 | CID000017732 | |
| Drug | chrysin | 4.13e-12 | 115 | 33 | 8 | ctd:C043561 | |
| Drug | indole-2-carboxylic acid | 5.06e-12 | 32 | 33 | 6 | CID000072899 | |
| Drug | NNAL | 5.06e-12 | 32 | 33 | 6 | CID000104856 | |
| Drug | Muracein C | 5.06e-12 | 32 | 33 | 6 | CID003086323 | |
| Drug | 2-hydroxyestrone | 5.94e-12 | 13 | 33 | 5 | ctd:C024980 | |
| Drug | alizarin | 5.94e-12 | 13 | 33 | 5 | ctd:C010078 | |
| Drug | AC1Q6OQG | 6.17e-12 | 33 | 33 | 6 | CID000009686 | |
| Drug | R(-)-Denopamine | 6.17e-12 | 33 | 33 | 6 | CID000003818 | |
| Drug | 6-methylsalicylic acid | 6.17e-12 | 33 | 33 | 6 | CID000011279 | |
| Drug | BP-3,6-quinol | 6.17e-12 | 33 | 33 | 6 | CID000119292 | |
| Drug | norbuprenorphine | 6.17e-12 | 33 | 33 | 6 | CID000114976 | |
| Drug | geniposide | 6.17e-12 | 33 | 33 | 6 | CID000107848 | |
| Disease | X-11442 measurement | 1.01e-16 | 9 | 33 | 6 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.01e-16 | 9 | 33 | 6 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.01e-16 | 9 | 33 | 6 | EFO_0004739 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.01e-16 | 9 | 33 | 6 | EFO_0004570, GO_0009410 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 2.53e-16 | 10 | 33 | 6 | EFO_0802185 | |
| Disease | bilirubin measurement, response to tenofovir | 2.53e-16 | 10 | 33 | 6 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 5.56e-16 | 11 | 33 | 6 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 5.56e-16 | 11 | 33 | 6 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 5.56e-16 | 11 | 33 | 6 | EFO_0800972 | |
| Disease | aldosterone measurement | 5.56e-16 | 11 | 33 | 6 | EFO_0010219 | |
| Disease | biliverdin measurement | 1.11e-15 | 12 | 33 | 6 | EFO_0021033 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.27e-15 | 5 | 33 | 5 | EFO_0801060 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.27e-15 | 5 | 33 | 5 | EFO_0801853 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.48e-14 | 17 | 33 | 6 | EFO_0004611, EFO_0007800 | |
| Disease | X-21339 measurement | 2.67e-14 | 7 | 33 | 5 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0021260 | |
| Disease | Succinimide measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0022118 | |
| Disease | X-11530 measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0800696 | |
| Disease | X-10458 measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0800692 | |
| Disease | X-24849 measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0802740 | |
| Disease | X-16946 measurement | 7.12e-14 | 8 | 33 | 5 | EFO_0800766 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.60e-13 | 9 | 33 | 5 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.60e-13 | 9 | 33 | 5 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.60e-13 | 9 | 33 | 5 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.60e-13 | 9 | 33 | 5 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.60e-13 | 9 | 33 | 5 | EFO_0020691 | |
| Disease | X-21448 measurement | 3.20e-13 | 10 | 33 | 5 | EFO_0800816 | |
| Disease | X-23974 measurement | 3.20e-13 | 10 | 33 | 5 | EFO_0800867 | |
| Disease | xanthurenate measurement | 5.64e-13 | 29 | 33 | 6 | EFO_0010551 | |
| Disease | pregnenetriol sulfate measurement | 5.86e-13 | 11 | 33 | 5 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 5.86e-13 | 11 | 33 | 5 | EFO_0600039 | |
| Disease | response to dolutegravir | 7.04e-13 | 30 | 33 | 6 | EFO_0600017 | |
| Disease | p-cresol glucuronide measurement | 1.00e-12 | 12 | 33 | 5 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 1.63e-12 | 13 | 33 | 5 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 1.63e-12 | 13 | 33 | 5 | EFO_0800587 | |
| Disease | 5-hydroxyindole sulfate measurement | 6.47e-12 | 5 | 33 | 4 | EFO_0800085 | |
| Disease | X-21441 measurement | 7.81e-12 | 17 | 33 | 5 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 1.08e-11 | 18 | 33 | 5 | EFO_0801382 | |
| Disease | tissue factor measurement | 2.56e-11 | 21 | 33 | 5 | EFO_0010623 | |
| Disease | urate measurement, spine bone mineral density | 4.70e-11 | 58 | 33 | 6 | EFO_0004531, EFO_0007701 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.23e-10 | 28 | 33 | 5 | EFO_0000389, EFO_0000621 | |
| Disease | hormone measurement | 4.62e-10 | 84 | 33 | 6 | EFO_0004730 | |
| Disease | vitamin D deficiency | 5.41e-10 | 37 | 33 | 5 | EFO_0003762 | |
| Disease | cholelithiasis | 6.14e-10 | 88 | 33 | 6 | EFO_0004799 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.27e-09 | 3 | 33 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 1.27e-09 | 3 | 33 | 3 | EFO_0800043 | |
| Disease | gallstones | 2.14e-09 | 108 | 33 | 6 | EFO_0004210 | |
| Disease | vitamin D measurement, COVID-19 | 2.35e-09 | 49 | 33 | 5 | EFO_0004631, MONDO_0100096 | |
| Disease | non-high density lipoprotein cholesterol measurement | UGT1A1 ENAM UGT1A9 NYAP2 APPL2 ZC3H4 UGT1A10 UGT1A8 UGT1A7 UGT1A6 | 3.57e-09 | 713 | 33 | 10 | EFO_0005689 |
| Disease | free androgen index | 6.51e-09 | 374 | 33 | 8 | EFO_0007005 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.37e-08 | 147 | 33 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 2.54e-08 | 6 | 33 | 3 | EFO_0800566 | |
| Disease | thyroxine measurement | 3.48e-08 | 83 | 33 | 5 | EFO_0005130 | |
| Disease | testosterone measurement | PKNOX2 UGT1A9 NYAP2 SEMA6D RBMS3 ZC3H4 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UBQLN4 | 7.56e-08 | 1275 | 33 | 11 | EFO_0004908 |
| Disease | indoleacetate measurement | 1.52e-07 | 10 | 33 | 3 | EFO_0021015 | |
| Disease | X-24588 measurement | 3.62e-07 | 13 | 33 | 3 | EFO_0800898 | |
| Disease | serum gamma-glutamyl transferase measurement | UGT1A9 NYAP2 SEMA6D RBMS3 UGT1A10 UGT1A8 UGT1A7 CREB5 UGT1A6 | 4.99e-07 | 914 | 33 | 9 | EFO_0004532 |
| Disease | metabolite measurement | 2.38e-06 | 560 | 33 | 7 | EFO_0004725 | |
| Disease | attention deficit hyperactivity disorder | 2.41e-06 | 354 | 33 | 6 | EFO_0003888 | |
| Disease | cervical cancer | 7.45e-06 | 34 | 33 | 3 | C4048328 | |
| Disease | Carcinoma, Granular Cell | 8.50e-06 | 116 | 33 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 8.50e-06 | 116 | 33 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 8.50e-06 | 116 | 33 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 8.50e-06 | 116 | 33 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 8.50e-06 | 116 | 33 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 8.50e-06 | 116 | 33 | 4 | C0001418 | |
| Disease | bilirubin measurement | 8.59e-06 | 442 | 33 | 6 | EFO_0004570 | |
| Disease | urinary bladder carcinoma | 2.00e-05 | 47 | 33 | 3 | MONDO_0004986 | |
| Disease | vitamin D measurement | 3.39e-05 | 336 | 33 | 5 | EFO_0004631 | |
| Disease | Prostatic Neoplasms | 5.54e-05 | 616 | 33 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.54e-05 | 616 | 33 | 6 | C0376358 | |
| Disease | urate measurement, bone density | 5.69e-05 | 619 | 33 | 6 | EFO_0003923, EFO_0004531 | |
| Disease | serum metabolite measurement | 6.97e-05 | 945 | 33 | 7 | EFO_0005653 | |
| Disease | dodecanedioate measurement | 7.95e-05 | 12 | 33 | 2 | EFO_0021054 | |
| Disease | Muscular Atrophy | 1.26e-04 | 15 | 33 | 2 | C0026846 | |
| Disease | Neurogenic Muscular Atrophy | 1.26e-04 | 15 | 33 | 2 | C0270948 | |
| Disease | Neurodevelopmental Disorders | 1.54e-04 | 93 | 33 | 3 | C1535926 | |
| Disease | Multiple congenital anomalies | 1.63e-04 | 17 | 33 | 2 | C0000772 | |
| Disease | Squamous cell carcinoma of esophagus | 1.64e-04 | 95 | 33 | 3 | C0279626 | |
| Disease | Squamous cell carcinoma | 3.60e-04 | 124 | 33 | 3 | C0007137 | |
| Disease | Malignant Neoplasms | 3.96e-04 | 128 | 33 | 3 | C0006826 | |
| Disease | Sezary Syndrome | 4.18e-04 | 27 | 33 | 2 | C0036920 | |
| Disease | ganglion cell inner plexiform layer thickness measurement | 4.50e-04 | 28 | 33 | 2 | EFO_0600005 | |
| Disease | glomerular filtration rate, response to platinum based chemotherapy | 4.50e-04 | 28 | 33 | 2 | EFO_0004647, EFO_0005208 | |
| Disease | ovarian neoplasm | 4.52e-04 | 134 | 33 | 3 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 4.82e-04 | 137 | 33 | 3 | C1140680 | |
| Disease | age at menarche | 4.84e-04 | 594 | 33 | 5 | EFO_0004703 | |
| Disease | hair colour measurement | 5.67e-04 | 615 | 33 | 5 | EFO_0007822 | |
| Disease | systolic blood pressure, body mass index | 6.65e-04 | 34 | 33 | 2 | EFO_0004340, EFO_0006335 | |
| Disease | prostate cancer (is_marker_for) | 7.04e-04 | 156 | 33 | 3 | DOID:10283 (is_marker_for) | |
| Disease | Uterine Cervical Neoplasm | 7.05e-04 | 35 | 33 | 2 | C0007873 | |
| Disease | hepatitis B (is_implicated_in) | 7.88e-04 | 37 | 33 | 2 | DOID:2043 (is_implicated_in) | |
| Disease | apolipoprotein B measurement | 7.95e-04 | 663 | 33 | 5 | EFO_0004615 | |
| Disease | Leukemia, Myelocytic, Acute | 9.50e-04 | 173 | 33 | 3 | C0023467 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPPNMMGAHTNNMMA | 771 | Q92793 | |
| MMPQQPVMFAQPMMR | 851 | O60641 | |
| MDHPMSMQPANMMGP | 321 | Q6XE24 | |
| MQRGMNMSVNLMPAP | 1961 | Q8WYB5 | |
| GHMMEMMGSRQDQTP | 256 | Q02930 | |
| NFPAMIPLWMFPMAM | 186 | Q02252 | |
| MMSMNSKQPHFAMHP | 1 | Q01851 | |
| QDALGMDPMMEHEMG | 726 | P35222 | |
| MDPMMEHEMGGHHPG | 731 | P35222 | |
| EPYISMDAMPGMQNM | 331 | Q6P499 | |
| MAQNNLGMPPMVMSR | 3111 | Q8NEZ4 | |
| HFRMGFMTMPAPQDR | 91 | Q9P242 | |
| MHYAPMGMHPMGQRA | 61 | O75400 | |
| MGMHPMGQRANMPPV | 66 | O75400 | |
| MGQRANMPPVPHGMM | 71 | O75400 | |
| ANIPMMGTHMPMAGD | 501 | Q9H3D4 | |
| MEMNRMIPGSQRHME | 656 | O00512 | |
| SHMQGMMGEQAPRMG | 1271 | O00512 | |
| FLQQGMMGPHHRMMS | 1321 | O00512 | |
| MMGPHHRMMSPAQST | 1326 | O00512 | |
| GMQSMPMEVPMNAMQ | 616 | Q86UU0 | |
| MMQAHRQMDPAMFPG | 711 | Q86UU0 | |
| RKQMAMMEPMIGFAH | 191 | Q8NEU8 | |
| NSVAMPMHMPRMPGF | 36 | Q9NRM1 | |
| MIGAPDMAFPRMNNM | 86 | P00395 | |
| MMQHASPAPALTMMA | 1 | Q96KN3 | |
| MHHRMNEMNLSPVGM | 1 | Q9UKN5 | |
| HMGWMMAVLPYNPNM | 186 | P03891 | |
| MSSRMGPSQNPMMQH | 1336 | Q9Y6Q9 | |
| MMAMNSKQPFGMHPV | 1 | Q15319 | |
| MADHMMAMNHGRFPD | 1 | Q99967 | |
| NGVPMVMMPLFGDQM | 381 | Q9HAW8 | |
| VPMVMMPLFGDQMDN | 386 | P22309 | |
| NGVPMVMMPLFGDQM | 381 | O60656 | |
| MKNQYMGNMSMPPPF | 506 | P49750 | |
| ADMHADMPMGPGMNP | 646 | Q9UPT8 | |
| SMMMATKNHGTPMPY | 561 | Q9C0D7 | |
| PMVMMPLFGDQMDNA | 386 | P19224 | |
| QMAHQNLMLDPMGSM | 901 | Q8NFY4 | |
| NPDLMRHMIMANPQM | 211 | Q9NRR5 | |
| NGVPMVMMPLFGDQM | 381 | Q9HAW7 | |
| NGVPMVMMPLFGDQM | 381 | Q9HAW9 |